Home › NDC Lookup › RxCUI directory › RxCUI 2695882

Zolbetuximab-clzb 100 MG Injection [Vyloy] — RxCUI 2695882

Name: Zolbetuximab-clzb 100 MG Injection [Vyloy] (RxCUI 2695882)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic branded drug

RxCUI 2695882 Semantic branded drug · SBD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2695882

Official nameZolbetuximab-clzb 100 MG Injection [Vyloy]

Concept typeSemantic branded drug (SBD)

RxNorm statusCurrent RxNorm concept

Also known asVyloy 100 MG Injection

FDA products mapped2

Package NDCs mapped2

Reported Medicaid activity (SDUD)361 prescriptions · 4 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Zolbetuximab: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

Vyloy is a targeted antibody that zeroes in on a protein called claudin 18.2 on the surface of your stomach or esophageal junction cancer cells. On its own, it isn't approved — it...
What exactly is Vyloy and why do I need chemotherapy with it?
Vyloy only works if your tumor cells actually have the claudin 18.2 (CLDN18.2) protein on their surface. An FDA-approved lab test checks a sample of your tumor for this protein. If...
Why do I need a special test before starting Vyloy?

📖 Read our full Zolbetuximab guide →

🕸️ Concept Web — How Zolbetuximab-clzb 100 MG Injection [Vyloy] Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Zolbetuximab-clzb 100 MG Injection [Vyloy] RxCUI 2695882 Semantic branded drug · SBD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Zolbetuximab 2695869 IN
- Zolbetuximab-clzb 2695870 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Vyloy 2695877 BN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Zolbetuximab Injection 2695873 SCDF
- Zolbetuximab-clzb Injection 2695875 SCDFP
- Zolbetuximab Injectable Product 2695872 SCDG
- Zolbetuximab-clzb Injectable Product 2695874 SCDGP
- Zolbetuximab Injection [Vyloy] 2695880 SBDF
- Zolbetuximab-clzb Injection [Vyloy] 2695881 SBDFP
- Vyloy Injectable Product 2695879 SBDG
- Injection 1649574 DF
- +1 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Zolbetuximab-clzb 100 MG Injection 2695876 SCD
- Zolbetuximab-clzb 100 MG 2695871 SCDC
- Zolbetuximab-clzb 100 MG [Vyloy] 2695878 SBDC

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Zolbetuximab-clzb 100 MG Injection SCD · 2695876
Zolbetuximab-clzb 100 MG SCDC · 2695871
Zolbetuximab Injection SCDF · 2695873
Zolbetuximab-clzb Injection SCDFP · 2695875
Zolbetuximab Injectable Product SCDG · 2695872
Zolbetuximab-clzb Injectable Product SCDGP · 2695874

Brand-Name Concepts

Zolbetuximab-clzb 100 MG [Vyloy] SBDC · 2695878
Zolbetuximab Injection [Vyloy] SBDF · 2695880
Zolbetuximab-clzb Injection [Vyloy] SBDFP · 2695881
Vyloy Injectable Product SBDG · 2695879
Vyloy BN · 2695877

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 2695882 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
00469-3425-10	1 VIAL in 1 BOX (0469-3425-10) / 5 mL in 1 VIAL	VYLOY	Astellas Pharma US, Inc.	2024-10-24
00469-4425-30	1 VIAL in 1 BOX (0469-4425-30) / 15 mL in 1 VIAL	VYLOY	Astellas Pharma US, Inc.	2025-04-24

Observed labelers: Astellas Pharma US, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.

Code	Descriptor	Mapped packages	Sources
J1326	Inj, zolbetuximab-clzb, 2 mg	2	CMS

⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.